The risk of autoimmunity associated with tumor immunotherapy

Research output: Contribution to journalComment/debatepeer-review

81 Scopus citations


In summary, tumor vaccination via the targeting of self-antigens expressed in tumor cells can be achieved without undue autoimmune pathology, largely due to an apparent difference between the requirements for inducing tumor regression and autoimmune pathology. Such treatments are, however, not without associated risks or the need for compromises and will require well thought-out choices to be made on a case-by-case basis.

Original languageEnglish (US)
Pages (from-to)789-792
Number of pages4
JournalNature Immunology
Issue number9
StatePublished - 2001
Externally publishedYes

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology


Dive into the research topics of 'The risk of autoimmunity associated with tumor immunotherapy'. Together they form a unique fingerprint.

Cite this